<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font5" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font6" size="12" family="URCYIA+Times" color="#000000"/>
<text top="41" left="55" width="254" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Current Controlled Trials in Cardiovascular Medicine 2005, 6 :15<i>Current Controlled Trials in Cardiovascular Medicine</i></text>
<text top="41" left="373" width="181" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://cvm.controlled-trials.com/content/6/1/15</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t3" reading_order_no="24" segment_no="5" tag_type="text">Page 4 of 9<b>6</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="25" segment_no="6" tag_type="text">(page number not for citation purposes)</text>
<text top="703" left="55" width="37" height="9" font="font4" id="p1_t5" reading_order_no="22" segment_no="3" tag_type="title">Figure 1</text>
<text top="714" left="55" width="16" height="9" font="font5" id="p1_t6" reading_order_no="23" segment_no="4" tag_type="text">text</text>
<text top="124" left="230" width="156" height="12" font="font6" id="p1_t7" reading_order_no="2" segment_no="2" tag_type="figure">Patients recruited before surgery<i>(page number not for citation purposes)</i></text>
<text top="160" left="223" width="168" height="12" font="font6" id="p1_t8" reading_order_no="3" segment_no="2" tag_type="figure">Preoperative CBC and lipid profile<b>Figure 1</b></text>
<text top="230" left="209" width="198" height="12" font="font6" id="p1_t9" reading_order_no="5" segment_no="2" tag_type="figure">Randomization when chest tube drainage</text>
<text top="244" left="264" width="84" height="12" font="font6" id="p1_t10" reading_order_no="6" segment_no="2" tag_type="figure">&lt; 50 cc/hr x 2 hrs</text>
<text top="368" left="194" width="225" height="12" font="font6" id="p1_t11" reading_order_no="10" segment_no="2" tag_type="figure">Patients withdrawn from study if postoperative</text>
<text top="382" left="182" width="246" height="12" font="font6" id="p1_t12" reading_order_no="11" segment_no="2" tag_type="figure">bleeding complications, warfarin requirements, etc.</text>
<text top="454" left="210" width="191" height="12" font="font6" id="p1_t13" reading_order_no="13" segment_no="2" tag_type="figure">CBC and lipid profile at one month F/U</text>
<text top="640" left="218" width="158" height="12" font="font6" id="p1_t14" reading_order_no="21" segment_no="2" tag_type="figure">IVUS and angiogram at one year</text>
<text top="603" left="217" width="181" height="12" font="font6" id="p1_t15" reading_order_no="20" segment_no="2" tag_type="figure">CBC and lipid profile at one year F/U</text>
<text top="280" left="166" width="271" height="12" font="font6" id="p1_t16" reading_order_no="7" segment_no="2" tag_type="figure">Clopidogrel 75 mg or placebo, plus daily aspirin 162 mg</text>
<text top="197" left="243" width="130" height="12" font="font6" id="p1_t17" reading_order_no="4" segment_no="2" tag_type="figure">CABG or OPCAB Surgery</text>
<text top="315" left="217" width="181" height="12" font="font6" id="p1_t18" reading_order_no="8" segment_no="2" tag_type="figure">Postoperative chest tube drainage and</text>
<text top="329" left="228" width="156" height="12" font="font6" id="p1_t19" reading_order_no="9" segment_no="2" tag_type="figure">bleeding complications recorded</text>
<text top="418" left="269" width="78" height="12" font="font6" id="p1_t20" reading_order_no="12" segment_no="2" tag_type="figure">Discharge home</text>
<text top="499" left="149" width="138" height="12" font="font6" id="p1_t21" reading_order_no="14" segment_no="2" tag_type="figure">Physician follow-up at 1 and</text>
<text top="513" left="196" width="44" height="12" font="font6" id="p1_t22" reading_order_no="15" segment_no="2" tag_type="figure">6 months</text>
<text top="498" left="332" width="130" height="12" font="font6" id="p1_t23" reading_order_no="16" segment_no="2" tag_type="figure">Nurse phone calls at 3, 6, 9</text>
<text top="512" left="362" width="70" height="12" font="font6" id="p1_t24" reading_order_no="17" segment_no="2" tag_type="figure">and 12 months</text>
<text top="557" left="186" width="244" height="12" font="font6" id="p1_t25" reading_order_no="18" segment_no="2" tag_type="figure">Assessment of major adverse coronary events (MI,</text>
<text top="571" left="194" width="225" height="12" font="font6" id="p1_t26" reading_order_no="19" segment_no="2" tag_type="figure">CVA, angina, etc.) and bleeding complications</text>
</page>
</pdf2xml>
